| Expression of specific chemokines and chemokine receptors in the central nervous system of multiple sclerosis patients TL Sørensen, M Tani, J Jensen, V Pierce, C Lucchinetti, VA Folcik, S Qin, ... The Journal of clinical investigation 103 (6), 807-815, 1999 | 1225 | 1999 |
| Efficacy, durability, and safety of intravitreal faricimab up to every 16 weeks for neovascular age-related macular degeneration (TENAYA and LUCERNE): two randomised, double … JS Heier, AM Khanani, CQ Ruiz, K Basu, PJ Ferrone, C Brittain, ... The Lancet 399 (10326), 729-740, 2022 | 324 | 2022 |
| CCR1+/CCR5+ mononuclear phagocytes accumulate in the central nervous system of patients with multiple sclerosis C Trebst, TL Sørensen, P Kivisäkk, MK Cathcart, J Hesselgesser, R Horuk, ... The American journal of pathology 159 (5), 1701-1710, 2001 | 298 | 2001 |
| Chemokines and chemokine receptors in inflammation of the nervous system: manifold roles and exquisite regulation. DR Huang, Y Han, MR Rani, A Glabinski, C Trebst, T Sorensen, M Tani, ... Immunological reviews 177 (1), 2000 | 292 | 2000 |
| Multiple sclerosis: a study of CXCL10 and CXCR3 co-localization in the inflamed central nervous system TL Sørensen, C Trebst, P Kivisäkk, KL Klaege, A Majmudar, R Ravid, ... Journal of neuroimmunology 127 (1-2), 59-68, 2002 | 287 | 2002 |
| Ticagrelor in patients with diabetes and stable coronary artery disease with a history of previous percutaneous coronary intervention (THEMIS-PCI): a phase 3, placebo … DL Bhatt, PG Steg, SR Mehta, LA Leiter, T Simon, K Fox, C Held, ... The Lancet 394 (10204), 1169-1180, 2019 | 204 | 2019 |
| T-cells in the cerebrospinal fluid express a similar repertoire of inflammatory chemokine receptors in the absence or presence of CNS inflammation: implications for CNS trafficking P Kivisäkk, C Trebst, Z Liu, BH Tucky, TL Sørensen, RA Rudick, M Mack, ... Clinical & Experimental Immunology 129 (3), 510-518, 2002 | 187 | 2002 |
| Tachyphylaxis during treatment of exudative age-related macular degeneration with ranibizumab MS Eghøj, TL Sørensen British Journal of Ophthalmology 96 (1), 21-23, 2012 | 186 | 2012 |
| Optic neuritis as onset manifestation of multiple sclerosis: a nationwide, long-term survey TL Sørensen, JL Frederiksen, H Brønnum-Hansen, HC Petersen Neurology 53 (3), 473-473, 1999 | 186 | 1999 |
| Chemokines and matrix metalloproteinase-9 in leukocyte recruitment to the central nervous system F Sellebjerg, TL Sørensen Brain research bulletin 61 (3), 347-355, 2003 | 148 | 2003 |
| Chemokines CXCL10 and CCL2: differential involvement in intrathecal inflammation in multiple sclerosis TL Sørensen, F Sellebjerg, CV Jensen, RM Strieter, RM Ransohoff European journal of neurology 8 (6), 665-672, 2001 | 144 | 2001 |
| Age-related macular degeneration: A two-level model hypothesis MP Rozing, JA Durhuus, MK Nielsen, Y Subhi, TBL Kirkwood, ... Progress in retinal and eye research 76, 100825, 2020 | 143 | 2020 |
| Cerebrospinal fluid levels of chitinase 3-like 1 and neurofilament light chain predict multiple sclerosis development and disability after optic neuritis S Modvig, M Degn, H Roed, TL Sørensen, HBW Larsson, AR Langkilde, ... Multiple Sclerosis Journal 21 (14), 1761-1770, 2015 | 139 | 2015 |
| Chemokine CCL2 and chemokine receptor CCR2 in early active multiple sclerosis TL Sørensen, RM Ransohoff, RM Strieter, F Sellebjerg European journal of neurology 11 (7), 445-449, 2004 | 131 | 2004 |
| Four-year treatment results of neovascular age-related macular degeneration with ranibizumab and causes for discontinuation of treatment MK Falk, H Kemp, TL Sørensen American journal of ophthalmology 155 (1), 89-95. e3, 2013 | 120 | 2013 |
| Distinct chemokine receptor and cytokine expression profile in secondary progressive MS TL Sørensen, F Sellebjerg Neurology 57 (8), 1371-1376, 2001 | 88 | 2001 |
| A normative reference database study for Pronosco X-posure System™ DM Black, L Palermo, T Sørensen, JT Jørgensen, C Lewis, F Tylavsky, ... Journal of Clinical Densitometry 4 (1), 5-12, 2001 | 80 | 2001 |
| No cases of endophthalmitis after 20,293 intravitreal injections in an operating room setting T Brynskov, H Kemp, TL Sørensen Retina 34 (5), 951-957, 2014 | 72 | 2014 |
| Systemic levels of interleukin-6 correlate with progression rate of geographic atrophy secondary to age-related macular degeneration MK Nielsen, Y Subhi, CR Molbech, MK Falk, MH Nissen, TL Sørensen Investigative ophthalmology & visual science 60 (1), 202-208, 2019 | 71 | 2019 |
| Age-related macular degeneration is associated with increased proportion of CD56+ T cells in peripheral blood C Faber, A Singh, MK Falk, HB Juel, TL Sørensen, MH Nissen Ophthalmology 120 (11), 2310-2316, 2013 | 67 | 2013 |
